YANG, YU LIN,杨堉麟,楊堉麟,HSIEH, PEI FANG,谢佩坊,謝佩坊,LIU, SHU FEN,刘淑芬,劉淑芬,HSIEH, CHANG CHI,谢长奇,謝長奇,HUNG, MIN YUAN,洪敏元,洪敏元,HUNG, CHIEN YA,洪千雅,洪千雅,CHEN, WEI MING,陈韦铭,陳韋銘
申请号：
TW100132738
公开号：
TWI415621B
申请日:
2011.09.09
申请国别(地区):
TW
年份:
2013
代理人:
摘要：
Usage of interleukin-7 for manufacturing drug of kidney fibrosis, wherein interleukin-7 inhibits the kidney fibrosis when the kidney cells stimulated by physiological or non-physiological stimulation is disclosed. Prepareingof a medication for treatment of kidney fibrosis is also disclosed. The medication comprises interleukin-7 as active element, and at least one medical acceptable adjuvant or carrier, which combines with interleukin-7 to form the medication.一種介白素7用以製備治療腎纖維化藥物之用途,介白素7係具有抑制腎臟細胞在受到生理性或非生理性刺激的情況而發生腎纖維化之作用。另提供一種醫藥組合物用以製備治療腎纖維化之藥物的用途,該醫藥組合物係包含介白素7,作為腎纖維化之活性成分,該醫藥組合物更包含至少一種醫藥可接受之藥物佐劑或藥物載劑與介白素7結合。
